Smart Scholars🛡 Scholar Shield🏛 Research Integrity Desk🧩 Portfolio Console📰 Journals🔧 DOI MembersTools🔎 Journal AuditGI GetIndexedDr DOI Doctor

10.46243/jst.2021.v6.i3.pp75-79 registered

A Review on Formulation and Evaluation of Nifedipine Sublingual Tablets

Resolves to https://www.jst.org.in/index.php/pub/article/view/819

Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2021.v6.i3.pp75-79

Registered 29 Sep 2026 via crossref · record version 2 · last change 30 Sep 2026, 12:00 AM · record sha256 26ce402edc28c321…

Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)

What the DOI identifies

JournalArticle — an article in a journal · Digital · Visual · en

A Review on Formulation and Evaluation of Nifedipine Sublingual Tablets (PrincipalTitle)

Published 2021-05-27

Part of Journal of Science & Technology · ISSN 2456-5660 · volume 06 · issue 03 · pages 75–79

Agents

  • Amit A. Khachane (author)
  • Longman Publishers (publisher)

Identifiers DOI 10.46243/jst.2021.v6.i3.pp75-79

Abstract

The aim of this study was to evaluate the effect of increasing nifedipine load on the characteristics of fast-disintegrating sublingual tablets for the potential emergency treatment of anginal pain and hypertension. Nifedipine undergoes first pass metabolism in liver and gut wall which has oral bioavailability of 43-77%. Sublingual dosage form bypasses the metabolism of the nifedipine in liver and offers a fast relieve from anginal pain and hypertension. An attempt has been made to prepare fast dissolving tablets of nifedipine using super distintegrants like Cross Carmellose Sodium, Sodium Starch Glycolate, CrosPovidone. Three different groups of formulations (A, R, and V) with variation in tablet excipients were prepared by direct compression method.Tablet weight variation, hardness, friability, drug content, disintegration time and dissolution time were evaluated for each formulation and found satisfactory. The studied sublingual tablet group V shows a lesser T50% compared to commercial oral tablet. The Group V also indicates the fast dissolution and disintegration rate of the optimized nifedipine sublingual tablet, which is prerequisite for rapid management of anginal and hypertension diseases.

Licence https://creativecommons.org/licenses/by/4.0/

System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1

Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.

ElementValueIn the record
DOI Name
DOI name
10.46243/jst.2021.v6.i3.pp75-79doi
Referent Type
referentType
Creationreferent
Referent Sub-Type
referentSubType
JournalArticle — an article in a journaltype
Referent Name(s)
referentName(s)
A Review on Formulation and Evaluation of Nifedipine Sublingual Tablets (PrincipalTitle, en)titles
Basic Metadata
basicMetadata
author: Amit A. Khachane
publisher: Longman Publishers
published: 2021-05-27
part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 06 · no. 03 · pp. 75–79
language: en
form: Digital · Visual · Language
agents, dates, container, language, structural_type, modes, characters
Referent Identifier(s)
alternateIdentifier(s)
none besides the DOIidentifiers, relations (IsSameAs)
Registration Authority
registrationAuthorityCode
Crossref — issued by Crossref (member 25296); held here as a copyrecord.source_agency (our code, ra_doi_name, for names issued here once appointed)
Created Date
issueDate
2026-09-12record.registered (when the DOI name was first registered)
relatedIdentifiersnone needed — the descriptive metadata is in this recordcontainer, relations (only where the descriptive metadata lives at another identifier)

complete Every System Metadata element is here, with the basic metadata a journal article needs.

The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs

History — the ledger

Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.

#WhenWhatByChanges
129 Sep 2026, 10:00 PMregister
registered at Crossref; record read from api.crossref.org
Administrator (admin) 84 fields set · sha256 4b13a63d5a33…
230 Sep 2026, 12:00 AMupdate
record re-read from api.crossref.org
Administrator (admin)
container.titles.0.value: Journal of Science & Technology → Journal of Science & Technology

Machine-readable: the history as JSON, with the full record after each change.

Everything Smart Scholars runsNine sites, one account. A journal starts at the audit; an author starts at Scholar Shield.

For journals & publishers

Start with the audit — it is free, and it is the gate to everything else.

DOI care

Nine services on one journal profile — each previews first and acts only on your approval.

For authors & researchers

Free to use. Nothing you check is shared with the journal.

For institutions, sponsors & DOI operators

Smart Scholars

Mon–Sat, 10:00–19:00 IST. The Ask AI button on every page answers about our services at any hour.

News

Policies

What we can register a DOI for

20 kinds of record, one account, one place. Every one gets a DOI that resolves, metadata that indexes read, and a record that stays correct afterwards.
Journals
  • Journal articles
  • Journal titles
  • Pending publications
  • Peer reviews
  • Preprints & posted content
Books & conferences
  • Books
  • Book chapters
  • Book series
  • Book sets
  • Conference proceedings
  • Proceedings series
  • Conference papers
Other research output
  • Theses & dissertations
  • Reports & working papers
  • Report series
  • Standards
  • Databases
  • Datasets
  • Figures, tables & supplements
Funding
  • Grants & funding awards

Elsewhere

The same company, in the places our publishers already read.
Smart Scholars · Every service on one pageData from OpenAlex (openalex.org), CC0 · Crossref · ISSN Portal · DOAJContact
WhatsApp